Correlation Between Virpax Pharmaceuticals and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Theriva Biologics, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Theriva Biologics.
Diversification Opportunities for Virpax Pharmaceuticals and Theriva Biologics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Theriva is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Theriva Biologics go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Theriva Biologics
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to generate 1.32 times more return on investment than Theriva Biologics. However, Virpax Pharmaceuticals is 1.32 times more volatile than Theriva Biologics. It trades about -0.01 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.03 per unit of risk. If you would invest 750.00 in Virpax Pharmaceuticals on August 30, 2024 and sell it today you would lose (703.70) from holding Virpax Pharmaceuticals or give up 93.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Theriva Biologics
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Theriva Biologics |
Virpax Pharmaceuticals and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Theriva Biologics
The main advantage of trading using opposite Virpax Pharmaceuticals and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| Virpax Pharmaceuticals vs. Bright Minds Biosciences | Virpax Pharmaceuticals vs. HP Inc | Virpax Pharmaceuticals vs. Intel | Virpax Pharmaceuticals vs. Chevron Corp |
| Theriva Biologics vs. Lumos Pharma | Theriva Biologics vs. Avalo Therapeutics | Theriva Biologics vs. Virpax Pharmaceuticals | Theriva Biologics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |